Differential binding affinities of sugar-modified derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine for herpes simplex virus-induced and human cellular deoxythymidine kinases.
暂无分享,去创建一个
E. De Clercq | Y. Cheng | G. Dutschman | F. Zou | Y. Cheng
[1] Y. Cheng,et al. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases , 1981, Antimicrobial Agents and Chemotherapy.
[2] Y. Cheng,et al. Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy , 1980, Antimicrobial Agents and Chemotherapy.
[3] R. T. Walker,et al. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. , 1980, The Journal of infectious diseases.
[4] W. Prusoff,et al. Phosphorylation of 5-iodo-5'-amino-2',5',dideoxyuridine by herpes simplex virus type 1 encoded thymidine kinase. , 1979, The Journal of biological chemistry.
[5] T. Hackstadt,et al. Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase , 1979, Journal of virology.
[6] D. Campbell,et al. Antiviral Activity of Arabinosylthymine in Herpesviral Replication: Mechanism of Action In Vivo and In Vitro , 1977, Antimicrobial Agents and Chemotherapy.
[7] Yung‐chi Cheng. A RATIONAL APPROACH TO THE DEVELOPMENT OF ANTIVIRAL CHEMOTHERAPY: ALTERNATIVE SUBSTRATES OF HERPES SIMPLEX VIRUS TYPE 1 (HSV‐1) AND TYPE 2 (HSV‐2) THYMIDINE KINASE (TK) * , 1977, Annals of the New York Academy of Sciences.
[8] S. Greer,et al. Enzymatic basis for the selective inhibition of varicella-zoster virus by 5-halogenated analogues of deoxycytidine , 1976, Journal of virology.
[9] Y. Cheng,et al. Deoxythymidine kinase induced in HeLa TK- cells by herpes simplex virus type I and type II. II. Purification and characterization. , 1976, The Journal of biological chemistry.
[10] S. Greer,et al. An assay for pyrimidine deoxyribonucleoside kinase using γ-32P-labeled ATP , 1975 .
[11] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.